ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for low platelets after transplant: baricitinib trial launches
Disease control Not yet recruitingThis study tests the safety and effectiveness of baricitinib in adults with persistently low platelets after a stem cell transplant, who did not respond to standard treatments. About 28 participants will receive baricitinib to see if it can raise platelet counts without needing t…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 01, 2026 17:41 UTC
-
400-Patient study aims to uncover hidden heart dangers in stem cell transplants
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving stem cell transplants for blood cancers to better understand why some develop serious heart problems like heart attacks, irregular heartbeats, or heart failure. Researchers will use heart scans, blood tests, and other monitoring to find…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC